Literature DB >> 25873830

Primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction in a patient taking dabigatran for chronic anticoagulation.

Imdad Ahmed, Stephen J Voyce.   

Abstract

Interventional cardiologists have few data on which to base clinical decisions regarding optimal care for ST-segment-elevation myocardial infarction patients who are taking therapeutic chronic oral anticoagulation. We present what we believe to be the first reported case of emergency coronary angiography and primary percutaneous coronary intervention in an ST-segment-elevation myocardial infarction patient who was on a dabigatran regimen for atrial fibrillation. The patient tolerated the procedures well and had no observable bleeding sequelae. In addition to the patient's case, we discuss the current evidence regarding the periprocedural management of oral anticoagulation in patients who need coronary angiography and percutaneous coronary intervention.

Entities:  

Keywords:  Anticoagulants/administration & dosage/adverse effects/therapeutic use; clinical protocols/standards; medication therapy management/standards; myocardial infarction/therapy; myocardial revascularization; percutaneous coronary intervention; risk assessment; thrombolytic therapy; treatment outcome

Mesh：

Substances：

Year:  2015        PMID： 25873830      PMCID： PMC4382885          DOI： 10.14503/THIJ-13-3727

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  16 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine.

Authors:  Thomas M Bashore; Stephen Balter; Ana Barac; John G Byrne; Jeffrey J Cavendish; Charles E Chambers; James Bernard Hermiller; Scott Kinlay; Joel S Landzberg; Warren K Laskey; Charles R McKay; Julie M Miller; David J Moliterno; John W M Moore; Sandra M Oliver-McNeil; Jeffrey J Popma; Carl L Tommaso
Journal:  J Am Coll Cardiol       Date:  2012-05-08       Impact factor: 24.094

3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

4.  2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Hani Jneid; Jeffrey L Anderson; R Scott Wright; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Jeffrey L Anderson
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

Review 5.  Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis.

Authors:  Erin Jamula; Nancy S Lloyd; Jon-David Schwalm; K E Juhani Airaksinen; James D Douketis
Journal:  Chest       Date:  2010-04-30       Impact factor: 9.410

6.  How does warfarin affect the activated coagulation time?

Authors:  R J Chang; T M Doherty; S L Goldberg
Journal:  Am Heart J       Date:  1998-09       Impact factor: 4.749

Review 7.  Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.

Authors:  Ken Uchino; Adrian V Hernandez
Journal:  Arch Intern Med       Date:  2012-01-09

8.  Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Authors:  Lars Wallentin; Salim Yusuf; Michael D Ezekowitz; Marco Alings; Marcus Flather; Maria Grazia Franzosi; Prem Pais; Antonio Dans; John Eikelboom; Jonas Oldgren; Janice Pogue; Paul A Reilly; Sean Yang; Stuart J Connolly
Journal:  Lancet       Date:  2010-09-18       Impact factor: 79.321

9.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Authors:  Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Journal:  Lancet       Date:  2011-04-04       Impact factor: 79.321

10.  Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.

Authors:  David B Jessup; Andrew T Coletti; Joseph B Muhlestein; William H Barry; Frederic C Shean; Brian K Whisenant
Journal:  Catheter Cardiovasc Interv       Date:  2003-10       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.